WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.28 Cr | ₹-0.57 Cr | ₹-2.03 Cr | ₹-2.04 Cr | ₹0.68 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of WINDLAS BIOTECH ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-0.28 Cr |
| Mar2024 | ₹-0.57 Cr |
| Mar2023 | ₹-2.03 Cr |
| Mar2022 | ₹-2.04 Cr |
| Mar2021 | ₹0.68 Cr |
How is Deferred Tax Assets / Liabilities of WINDLAS BIOTECH Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.28 Cr | Negative | |
| Mar2024 | ₹-0.57 Cr | Negative | |
| Mar2023 | ₹-2.03 Cr | Negative | |
| Mar2022 | ₹-2.04 Cr | Negative | |
| Mar2021 | ₹0.68 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,633.2 Cr | 1.1% | 2.6% | -26.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,495.0 Cr | -5.7% | -3.3% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹154,244.0 Cr | -3.1% | -9.3% | 0% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,634.0 Cr | -6.1% | -8.3% | 23.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,594.0 Cr | -5.1% | -6% | 4.8% | Stock Analytics | |
| CIPLA | ₹97,022.8 Cr | -3.3% | -11.2% | -19.5% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | 1.1% |
2.6% |
-26.9% |
| SENSEX | -1.6% |
-8.8% |
-4.1% |
You may also like the below Video Courses